No Data
Does Winning Health Technology Group (SZSE:300253) Have A Healthy Balance Sheet?
Winning Health Technology Group Co., Ltd.'s (SZSE:300253) P/E Is Still On The Mark Following 26% Share Price Bounce
GF SEC: The recovery of Medical IT Orders in February, pay attention to the subsequent implementation of AI Orders.
With the continuous deepening of AI technology applications and the increasingly sound Medical data security and compliance framework, it is expected that the demand for Medical IT will steadily rise in the next 3-5 years.
Winning Health Technology Group (300253.SZ): Focused on empowering Healthcare Informatization and Internet Hospital systems through AI technology.
On February 26, Gloshow reported that Winning Health Technology Group (300253.SZ) stated on the investor interaction platform that according to the "Guidelines for Application Scenarios of AI in the Medical Industry" jointly issued by the National Health Commission and three other departments in November 2024, the definition of "Medical Consultation Robot" is: it utilizes language large models, intelligent algorithms, and medical knowledge bases to engage in intelligent dialogue with patients, providing medical information consultation, assisting in appointment scheduling for consultations and examinations, thereby enhancing the convenience and accuracy of patients' medical visits. Winning Health has realized intelligent guidance and service through the patient service digital human built by the medical large model WiNGPT.
Retail Investors Invested in Winning Health Technology Group Co., Ltd. (SZSE:300253) up 4.3% Last Week, Insiders Too Were Rewarded
Orient: AI empowers Biomedical, with technology and policies supporting.
Since 2024, policies related to AI have been released intensively, providing comprehensive support for the development of Medical AI from the perspectives of development, application scenarios, and standard formulation.
Be Wary Of Winning Health Technology Group (SZSE:300253) And Its Returns On Capital
